Valuation: Tristel plc

Market Cap 207M 276M 245M 227M 390M 26.17B 396M 2.73B 1.07B 13.66B 1.03B 1.01B 43.54B P/E 2026 *
26.3x
P/E 2027 * 22.7x
Enterprise Value 197M 263M 234M 217M 372M 24.96B 378M 2.6B 1.02B 13.02B 987M 966M 41.52B EV / Sales 2026 *
3.85x
EV / Sales 2027 * 3.47x
Free-Float
93.07%
Yield 2026 *
3.46%
Yield 2027 * 3.66%
1 day-0.23%
1 week-0.58%
Current month+4.88%
1 month+9.55%
3 months+13.16%
6 months+11.69%
Current year+2.99%
1 week 425
Extreme 425
445
1 month 390
Extreme 390
445
Current year 350
Extreme 350
450
1 year 350
Extreme 350
450
3 years 260
Extreme 260
510
5 years 260
Extreme 260
510
10 years 140
Extreme 140
680
Manager TitleAgeSince
Chief Executive Officer 64 31/07/2026
Director of Finance/CFO - 31/12/2024
Chief Executive Officer - 29/06/2026
Director TitleAgeSince
Director/Board Member 54 18/10/2017
Chairman 65 16/12/2019
Director/Board Member 68 26/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
23/03/26 Buy

Director

2,597 0.0054%
03/03/26 Buy

Director

770 0.0016%
03/03/26 Buy

Director

1,540 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%-0.58%+21.13%+4.24% 276M
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 116B
+0.49%+6.25%-20.20%+11.58% 113B
+3.83%+5.50%-44.18%-6.77% 79.83B
-0.14%+5.27%+6.74%+82.45% 65.06B
+2.79%+2.37%+15.93%+68.64% 54.35B
-1.04%+4.35%+3.50%-26.18% 52.23B
+2.41%+8.18%-12.08%+30.45% 44.15B
-1.90%+2.29%+29.72%+8.98% 32.47B
Average +0.65%+4.70%-1.76%+21.92% 73.89B
Weighted average by Cap. +0.62%+5.59%-9.68%+22.13%

Financials

2026 *2027 *
Net sales 51.15M 68.23M 60.65M 56.22M 96.52M 6.48B 98.06M 676M 265M 3.38B 256M 251M 10.77B 56.28M 75.08M 66.74M 61.86M 106M 7.13B 108M 744M 292M 3.72B 282M 276M 11.85B
Net income 7.93M 10.58M 9.41M 8.72M 14.97M 1B 15.21M 105M 41.09M 524M 39.72M 38.87M 1.67B 9.19M 12.26M 10.9M 10.1M 17.35M 1.16B 17.63M 121M 47.62M 607M 46.03M 45.05M 1.94B
Net Debt -9.59M -12.79M -11.37M -10.54M -18.09M -1.21B -18.38M -127M -49.66M -633M -47.99M -46.97M -2.02B -11.29M -15.07M -13.39M -12.41M -21.31M -1.43B -21.65M -149M -58.5M -746M -56.54M -55.34M -2.38B
Projected Income Statement - Annual - Tristel plc
Logo Tristel plc
Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Employees
270
Date Price Change Volume
16/10/26 GBX 430.00 -0.23% 57,567
15/10/26 GBX 431.00 -0.92% 99,177
14/10/26 GBX 435.00 -0.23% 83,282
13/10/26 GBX 436.00 +0.23% 53,260
12/10/26 GBX 435.00 +0.58% 40,562
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Tristel plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.300GBP
Average target price
4.752GBP
Spread / Average Target
+10.51%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tristel plc
  1. Stock Market
  2. Stocks
  3. TSTL Stock